v3.26.1
Condensed Statement of Changes In Shareholders Equity (Deficit) (Unaudited) - 3 months ended Mar. 31, 2026 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 996 $ 24,004 $ (47,937) $ (22,937)
Balance (in Shares) at Dec. 31, 2025 9,966,667 [1]      
Sale of 150,000 Private Placement Units $ 15 1,499,985 1,500,000
Sale of 150,000 Private Placement Units (in Shares) 150,000 [1]      
Fair value of Public Warrants at issuance 1,562,275 1,562,275
Fair value of Representative Founder Shares 720,590 720,590
Allocated value of transaction costs to Public Warrants (26,154) (26,154)
Fair Value of Founder Shares transferred to directors 964,000 964,000
Accretion for Class A Ordinary Shares to redemption amount (4,744,700) (1,743,333) (6,488,033)
Net income 366,020 366,020
Balance at Mar. 31, 2026 $ 15 $ 996 $ (1,425,250) $ (1,424,239)
Balance (in Shares) at Mar. 31, 2026 150,000 9,966,667 [1]      
[1] Included up to 1,300,000 Class B Ordinary Shares subject to forfeiture if the Over-Allotment Option was not exercised in full or in part by the Underwriters. On February 5, 2026, the Underwriters exercised their Over-Allotment Option in full as part of the closing of the Initial Public Offering. As such, the 1,300,000 Class B Ordinary Shares are no longer subject to forfeiture (Note 5).